| human | Q5 |
| P496 | ORCID iD | 0000-0003-4748-8288 |
| P108 | employer | Facultad de Medicina (Universidad Complutense de Madrid) | Q5855044 |
| Hospital Universitario 12 de Octubre | Q5902531 | ||
| P735 | given name | Carlos | Q364753 |
| Carlos | Q364753 | ||
| P106 | occupation | researcher | Q1650915 |
| P5008 | on focus list of Wikimedia project | WikiProject COVID-19 | Q87748614 |
| P21 | sex or gender | male | Q6581097 |
| Q40694729 | A case of testicular nocardiosis and literature review. |
| Q43290194 | A new strategy of delayed long-term prophylaxis could prevent cytomegalovirus disease in (D+/R-) solid organ transplant recipients. |
| Q36681922 | A review of critical periods for opportunistic infection in the new transplantation era. |
| Q80355811 | Advanced donor age increases the risk of severe recurrent hepatitis C after liver transplantation |
| Q87164876 | Antiphospholipid syndrome in a patient suffering from congenital dyserythropoietic anemia type III |
| Q27021357 | Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature |
| Q92006962 | COVID-19 in solid organ transplant recipients: a single-center case series from Spain |
| Q43034078 | Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation. |
| Q40055908 | Clinical implications of respiratory virus infections in solid organ transplant recipients: a prospective study. |
| Q74287244 | Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients |
| Q43035669 | Clinical significance of hepatitis C virus (HCV) infection in liver transplant recipients. Role of serology and HCV RNA detection. |
| Q82138686 | Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients |
| Q46700693 | Consensus document from GESITRA-SEIMC on the prevention and treatment of cytomegalovirus infection in transplanted patients |
| Q70582483 | Corynebacterium urealyticum: a new and threatening pathogen for the renal transplant patient |
| Q43848199 | Current alternatives in the treatment of Pneumocystis carinii pneumonia in patients with AIDS |
| Q38602983 | Cytomegalovirus infection in solid organ transplant recipients |
| Q43615612 | Cytomegaloviruses in the bronchoalveolar lavage fluids of immunocompromised patients: microbiological results and clinical significance |
| Q41104403 | Effect of delaying prophylaxis against CMV in D+/R- solid organ transplant recipients in the development of CMV-specific cellular immunity and occurrence of late CMV disease. |
| Q41128262 | Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients. |
| Q46873883 | Efficacy and safety of valgancyclovir as preemptive therapy for the prevention of cytomegalovirus disease in solid organ transplant recipients. |
| Q44735264 | Efficacy preemptive therapy with ganciclovir for the prevention of cytomegalovirus disease in liver transplant recipients |
| Q72537958 | Encrusted pyelitis and cystitis by Corynebacterium urealyticum (CDC group D2): a new and threatening complication following renal transplant |
| Q33908093 | Environmental Factors as Key Determinants for Visceral Leishmaniasis in Solid Organ Transplant Recipients, Madrid, Spain |
| Q72467490 | Etiopathogenesis and prognosis of centrilobular necrosis in hepatic grafts |
| Q92214258 | Executive summary of the Consensus Statement of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria o |
| Q53247012 | First Spanish series of intestinal transplantation in adult recipients. |
| Q34558710 | GESIDA/GESITRA-SEIMC, PNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patients in Spain (March, 2005) |
| Q37934102 | GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients. |
| Q31797604 | Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial. |
| Q44731672 | Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update |
| Q93036298 | HCV eradication with all-oral therapy in cirrhotic HIV-coinfected patients: an observational study of early changes in liver function and fibrosis tests |
| Q40510735 | Hemophagocytic lymphohistiocytosis: Analysis of 18 cases |
| Q73127310 | Hepatitis B vaccination results in 140 liver transplant recipients |
| Q45783784 | High incidence of posttransplant hepatitis and chronic rejection associated with hepatitis C virus infection in liver transplant recipients. |
| Q42279119 | Hypocomplementemia in kidney transplant recipients: impact on the risk of infectious complications |
| Q40999338 | Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation. |
| Q46407973 | Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation. |
| Q89004723 | Impact of functional status on 6-month mortality in elderly patients with acute venous thromboembolism: results from a prospective cohort |
| Q34003488 | Impact of hepatitis C virus infection on the risk of infectious complications after kidney transplantation: data from the RESITRA/REIPI cohort. |
| Q40203021 | Impact of severe hematological abnormalities in the outcome of hospitalized patients with influenza virus infection |
| Q30372284 | Impact of squalene-based adjuvanted influenza vaccination on graft outcome in kidney transplant recipients. |
| Q31107136 | Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group |
| Q84028359 | Infection prevention in solid organ transplantation |
| Q42260699 | Infection risk in kidney transplantation from uncontrolled donation after circulatory death donors. |
| Q40912977 | Infectious Complications Following Small Bowel Transplantation |
| Q72252063 | Infectious complications following pancreatic transplantation: incidence, microbiological and clinical characteristics, and outcome |
| Q41260471 | Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation |
| Q92028864 | Influence of viral load in the outcome of hospitalized patients with influenza virus infection |
| Q44646186 | Interferon gamma quantification in cerebrospinal fluid compared with PCR for the diagnosis of tuberculous meningitis. |
| Q44617810 | Invasive fungal infections in liver transplant recipients: analysis of 21 cases |
| Q82138058 | Is double renal transplantation a risk factor for cytomegalovirus disease? |
| Q71206202 | Kaposi's sarcoma developing in a liver graft |
| Q42223053 | Kinetics of peripheral blood lymphocyte subpopulations predicts the occurrence of opportunistic infection after kidney transplantation |
| Q35136336 | Lack of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood stem cell transplants. |
| Q77632455 | Liver transplantation in HBsAg+ patients: results according to patient selection and treatment strategies |
| Q70756287 | Liver transplantation in chronic viral B and C hepatitis |
| Q43038248 | Liver transplantation in patients with cirrhosis of unknown cause (cryptogenic cirrhosis): long-term follow-up. |
| Q49281857 | Liver transplantation using grafts from donors over 65 |
| Q40186956 | Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients |
| Q41111669 | Major bacterial infections following liver transplantation: a prospective study |
| Q72675273 | Meningoencephalitis and polyradiculoneuritis in adults: don't forget rubella |
| Q60261695 | Monitoring of Immunoglobulin Levels Identifies Kidney Transplant Recipients at High Risk of Infection |
| Q72901825 | OKT3/antithymocyte globulin immunoprophylaxis in the prevention of recurrence of acute vanishing bile duct syndrome in retransplanted patients |
| Q38416294 | Potential role of post-transplant hypogammaglobulinemia in the risk of Clostridium difficile infection after kidney transplantation: a case-control study |
| Q91244936 | Predictive factors of hepatitis C virus eradication after interferon-free therapy in HIV coinfection |
| Q44136068 | Prospective study of cytomegalovirus infection in liver transplant recipients |
| Q40462342 | Randomized study of cefepime versus ceftazidime plus amikacin in patients with solid tumors treated with high dose chemotherapy (HDC) and peripheral blood stem cell support (PBSCS) with febrile neutropenia. |
| Q43759182 | Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation. |
| Q34400792 | Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections |
| Q87360171 | Recurrent Aortitis Associated With IgG4-Related Disease |
| Q40621488 | Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial. |
| Q57568519 | Risk Factors Associated With Early Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: Results From a Multinational Matched Case-Control Study |
| Q57569335 | Risk Factors for Invasive Aspergillosis in Solid-Organ Transplant Recipients: A Case-Control Study |
| Q46508952 | Risk of superinfection related to antibiotic use. Are all antibiotics the same? |
| Q38947867 | Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients. |
| Q44126584 | Safety of liposomal amphotericin B in patients with high risk of nephrotoxicity |
| Q57569086 | Selective intestinal decontamination with fluoroquinolones for the prevention of early bacterial infections after liver transplantation |
| Q42248581 | Serum iron parameters in the early post-transplant period and infection risk in kidney transplant recipients |
| Q90228857 | Severe lymphopenia in hospitalized patients with influenza virus infection as a marker of a poor outcome |
| Q74429552 | Steroid withdrawal is safe and beneficial in stable cyclosporine-treated liver transplant patients |
| Q34555449 | Successful treatment of mucor infection after liver or pancreas-kidney transplantation. |
| Q43628358 | The treatment of acute liver failure due to fulminating hepatitis by total or partial orthotopic liver transplantation. The clinical results |
| Q71220542 | Transmission of tuberculosis during a long airplane flight |
| Q46676270 | Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain |
| Q77958693 | Treatment of mucor infection after liver or pancreas-kidney transplantation |
| Q44784829 | Universal prophylaxis with fluconazole for the prevention of early invasive fungal infection in low-risk liver transplant recipients |
| Q46497887 | Usefulness of antibiotic-lock technique in management of oncology patients with uncomplicated bacteremia related to tunneled catheters. |
| Q46508942 | Usefulness of liposomal amphotericin B for the prophylaxis of fungal infection in solid organ transplant recipients |
| Q79967852 | Valganciclovir preemptive therapy for the prevention of cytomegalovirus disease in high-risk seropositive solid-organ transplant recipients |
| Q45787054 | Value of a new four-antigen recombinant immunoblot assay in predicting recurrence of hepatitis C virus infection following liver transplantation. |
| Q50156524 | Yield of detection of Clostridium difficile toxin versus stool culture in the study of nosocomial diarrhea |
| Q72736769 | [Bacteremia and fungemia in solid organ transplantation] |
| Q80210446 | [Contribution of second-generation azoles in Candida spp. infections] |
| Q70617006 | [Endocarditis due to penicillin-sensitive and -resistant pneumococci: the current perspectives on the disease] |
| Q81643244 | [Impact of a non-compulsory antibiotic control program (PACTA): cost reductions and decreases in some nosocomial infections] |
| Q80510457 | [Infections in liver transplant recipients] |
| Q71889143 | [Lymphoproliferative syndromes associated to the Epstein Barr virus in organ transplants] |
| Q70782965 | [Necrotic surgical wound] |
| Q67996970 | [Nosocomial fungemia caused by Candida parapsilosis] |
| Q73736024 | [Prevention of infection in recipients of solid organ transplants] |
| Q67868217 | [Prophylaxis of cytomegalovirus infection in the transplant recipient] |
| Q69247651 | [Pulmonary hemorrhage associated with extracapillary proliferative glomerulonephritis] |
| Q72798425 | [Results of hepatic transplantation from donors older than 50 years of age. Comparison with other age groups] |
| Q84028040 | [Risk factors for cytomegalovirus in solid organ transplant recipients] |
| Q72568056 | [Transitory colonization by Scedosporium prolificans (inflatum) in a liver transplant recipient] |
| Q71963885 | [Use of DNA sequence hybridization with specific oligonucleotide probes to identify hepatitis C virus genotypes] |
| Q56777671 | [Xenozoonosis: infections associated with xenotransplantation] |
Search more.